T1	PROC 46 83	Estudio de la eficacia y la seguridad
T2	DISO 123 129	anemia
#1	AnnotatorNotes T2	C0002871; Anemia; Disease or Syndrome
T3	DISO 145 169	enfermedad renal crónica
#2	AnnotatorNotes T3	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T4	DISO 198 201	ERC
#3	AnnotatorNotes T4	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T5	PROC 252 317	ESTUDIO DE FASE III ALEATORIZADO, SIN ENMASCARAMIENTO, CONTROLADO
T6	PROC 343 376	EVALÚA LA EFICACIA Y LA SEGURIDAD
T7	DISO 429 435	ANEMIA
#4	AnnotatorNotes T7	C0002871; Anemia; Disease or Syndrome
T8	DISO 451 475	ENFERMEDAD RENAL CRÓNICA
#5	AnnotatorNotes T8	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T9	DISO 504 507	ERC
#6	AnnotatorNotes T9	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T10	CHEM 600 611	hemoglobina
#7	AnnotatorNotes T10	C0019046; Hemoglobin; Amino Acid, Peptide, or Protein · Biologically Active Substance
T11	ANAT 618 624	sangre
#8	AnnotatorNotes T11	C0005767; Blood; Body Substance
T12	DISO 717 723	Anemia
#9	AnnotatorNotes T12	C0002871; Anemia; Disease or Syndrome
T13	DISO 739 763	enfermedad renal crónica
#10	AnnotatorNotes T13	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T14	DISO 792 795	ERC
#11	AnnotatorNotes T14	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T15	PROC 873 884	Diagnóstico
#12	AnnotatorNotes T15	C0011900; Diagnosis; Diagnostic Procedure
T16	DISO 888 891	ERC
#13	AnnotatorNotes T16	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T17	CHEM 1091 1094	FEE
#14	AnnotatorNotes T17	C2917382; Erythropoiesis-stimulating Agent; Pharmacologic Substance [fármaco estimulantes de la eritropoyesis]
T18	DISO 1141 1153	Hipertensión
#15	AnnotatorNotes T18	C0020538; Hypertensive disease; Disease or Syndrome
T19	DISO 1171 1193	Insuficiencia cardíaca
#16	AnnotatorNotes T19	C0018801; Heart failure; Disease or Syndrome
T20	DISO 1263 1287	Síndrome coronario agudo
#17	AnnotatorNotes T20	C0948089; Acute Coronary Syndrome; Disease or Syndrome
T21	PROC 1289 1304	hospitalización
#18	AnnotatorNotes T21	C0019993; Hospitalization; Health Care Activity
T22	DISO 1309 1325	angina inestable
#19	AnnotatorNotes T22	C0002965; Angina, Unstable; Disease or Syndrome
T23	DISO 1328 1348	infarto de miocardio
#20	AnnotatorNotes T23	C0027051; Myocardial infarction; Disease or Syndrome | C0155626; Acute myocardial infarction; Disease or Syndrome
T24	PROC 1351 1378	revascularización coronaria
#21	AnnotatorNotes T24	C0877341; Coronary revascularisation; Therapeutic or Preventive Procedure
T25	CHEM 1537 1549	darbepoetina
#22	AnnotatorNotes T25	C0937950; darbepoetin alfa; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T26	PROC 1388 1403	hospitalización
#23	AnnotatorNotes T26	C0019993; Hospitalization; Health Care Activity
T27	DISO 1408 1441	insuficiencia cardíaca congestiva
#24	AnnotatorNotes T27	C0018802; Congestive heart failure; Disease or Syndrome
T28	DISO 1444 1469	accidente cerebrovascular
#25	AnnotatorNotes T28	C0038454; Cerebrovascular accident; Disease or Syndrome
T29	DISO 1517 1534	Hipersensibilidad
#26	AnnotatorNotes T29	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T30	CHEM 1586 1597	excipientes
#27	AnnotatorNotes T30	C0015237; Pharmaceutical Excipient; Biomedical or Dental Material
T31	ANAT 156 161	renal
#28	AnnotatorNotes T31	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T32	PROC 188 196	diálisis
#29	AnnotatorNotes T32	C0011946; Dialysis procedure; Therapeutic or Preventive Procedure | C4551529; Renal Dialysis; Therapeutic or Preventive Procedure
T33	PROC 220 228	diálisis
#30	AnnotatorNotes T33	C0011946; Dialysis procedure; Therapeutic or Preventive Procedure | C4551529; Renal Dialysis; Therapeutic or Preventive Procedure
T34	CHEM 380 390	VADADUSTAT
#31	AnnotatorNotes T34	C4519730; vadadustat; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T35	ANAT 462 467	RENAL
#32	AnnotatorNotes T35	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T36	PROC 494 502	DIÁLISIS
#33	AnnotatorNotes T36	C0011946; Dialysis procedure; Therapeutic or Preventive Procedure | C4551529; Renal Dialysis; Therapeutic or Preventive Procedure
T37	PROC 526 534	DIÁLISIS
#34	AnnotatorNotes T37	C0011946; Dialysis procedure; Therapeutic or Preventive Procedure | C4551529; Renal Dialysis; Therapeutic or Preventive Procedure
T38	DISO 582 624	Disminución de la hemoglobina en la sangre
T39	DISO 652 690	pérdida progresiva de la función renal
T40	ANAT 685 690	renal
#35	AnnotatorNotes T40	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T41	ANAT 750 755	renal
#36	AnnotatorNotes T41	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T42	PROC 782 790	diálisis
#37	AnnotatorNotes T42	C0011946; Dialysis procedure; Therapeutic or Preventive Procedure | C4551529; Renal Dialysis; Therapeutic or Preventive Procedure
T43	PROC 814 822	diálisis
#38	AnnotatorNotes T43	C0011946; Dialysis procedure; Therapeutic or Preventive Procedure | C4551529; Renal Dialysis; Therapeutic or Preventive Procedure
T44	PROC 958 966	diálisis
#39	AnnotatorNotes T44	C0011946; Dialysis procedure; Therapeutic or Preventive Procedure | C4551529; Renal Dialysis; Therapeutic or Preventive Procedure
T45	PROC 1012 1015	HGB
#40	AnnotatorNotes T45	C0518015; Hemoglobin measurement; Laboratory Procedure
T46	ANAT 1185 1193	cardíaca
#41	AnnotatorNotes T46	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T47	CHEM 1553 1563	vadadustat
#42	AnnotatorNotes T47	C4519730; vadadustat; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T48	ANAT 1272 1281	coronario
#43	AnnotatorNotes T48	C0205042; Coronary artery; Body Part, Organ, or Organ Component | C1269008; Entire coronary artery; Body Part, Organ, or Organ Component
T49	ANAT 1339 1348	miocardio
#44	AnnotatorNotes T49	C0027061; Myocardium; Tissue | C1284309; Entire myocardium; Tissue
T50	ANAT 1369 1378	coronaria
#45	AnnotatorNotes T50	C0205042; Coronary artery; Body Part, Organ, or Organ Component | C1269008; Entire coronary artery; Body Part, Organ, or Organ Component
T51	ANAT 1422 1430	cardíaca
#46	AnnotatorNotes T51	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T52	CHEM 87 97	vadadustat
#47	AnnotatorNotes T52	C4519730; vadadustat; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T53	CHEM 322 338	PRINCIPIO ACTIVO
#48	AnnotatorNotes T53	C1372955; Active ingredient; Chemical Viewed Functionally
T54	PROC 896 899	FGe
#49	AnnotatorNotes T54	C3811844; Estimated Glomerular Filtration Rate; Laboratory Procedure
T55	Date 13 17	2015
T56	LIVB 133 140	sujetos
#50	AnnotatorNotes T56	C0681850; Study Subject; Group
T57	Duration 162 169	crónica
#51	AnnotatorNotes T57	C0205191; chronic; Temporal Concept
T58	Neg_cue 170 172	no
T59	Neg_cue 202 204	no
T61	Route 395 403	VÍA ORAL
#52	AnnotatorNotes T61	C1527415; Oral Route of Drug administration; Functional Concept
T62	LIVB 439 446	SUJETOS
#53	AnnotatorNotes T62	C0681850; Study Subject; Group
T63	Duration 468 475	CRÓNICA
#54	AnnotatorNotes T63	C0205191; chronic; Temporal Concept
T64	Neg_cue 476 478	NO
T65	Neg_cue 508 510	NO
T66	LIVB 628 637	pacientes
#55	AnnotatorNotes T66	C0030705; Patients; Patient or Disabled Group
T67	LIVB 727 734	sujetos
#56	AnnotatorNotes T67	C0681850; Study Subject; Group
T68	Duration 756 763	crónica
#57	AnnotatorNotes T68	C0205191; chronic; Temporal Concept
T69	Neg_cue 764 766	no
T70	Neg_cue 796 798	no
T71	Age 853 861	≥18 años
T73	Neg_cue 937 939	no
T74	Duration 982 989	6 meses
T76	Duration 1098 1111	las 6 semanas
T79	Duration 1473 1487	las 12 semanas
T60	PROC 1232 1258	New York Heart Association
#58	AnnotatorNotes T60	C4706236; Assessment using New York Heart Association Classification; Health Care Activity
A1	Assertion T32 Negated
A2	Assertion T33 Negated
A3	Assertion T36 Negated
A4	Assertion T37 Negated
A5	Assertion T42 Negated
A6	Assertion T43 Negated
A7	Assertion T44 Negated
A8	Status T17 History_of
A9	Status T28 History_of
A10	Status T29 History_of
A11	Status T20 History_of
A12	Status T22 History_of
A13	Status T23 History_of
A14	Status T27 History_of
A15	Status T24 History_of
A16	Status T26 History_of
A17	Status T21 History_of
#59	AnnotatorNotes T1	 C0511730; Identify product efficacy and safety issues; Health Care
#60	AnnotatorNotes T6	 C0511730; Identify product efficacy and safety issues; Health Care
#61	AnnotatorNotes T5	C0282461; Phase 3 Clinical Trials; Research Activity + C0206035; Controlled Clinical Trials, Randomized; Research Activity + C1709323; Open Label Study; Research Activity
T72	Neg_cue 1154 1156	no
T75	Quantifier_or_Qualifier 1157 1167	controlada
A18	Assertion T75 Negated
T77	Observation 767 790	dependiente de diálisis
A19	Assertion T77 Negated
#62	AnnotatorNotes T77	C0524376; Dependence on renal dialysis; Finding | C2945570; Encounter due to dependence on renal dialysis; Finding
T78	Observation 799 822	dependiente de diálisis
A20	Assertion T78 Negated
#63	AnnotatorNotes T78	C0524376; Dependence on renal dialysis; Finding | C2945570; Encounter due to dependence on renal dialysis; Finding
T80	Observation 205 228	dependiente de diálisis
A21	Assertion T80 Negated
#64	AnnotatorNotes T80	C0524376; Dependence on renal dialysis; Finding | C2945570; Encounter due to dependence on renal dialysis; Finding
T81	Observation 479 502	DEPENDIENTE DE DIÁLISIS
A22	Assertion T81 Negated
#65	AnnotatorNotes T81	C0524376; Dependence on renal dialysis; Finding | C2945570; Encounter due to dependence on renal dialysis; Finding
T82	Observation 511 534	DEPENDIENTE DE DIÁLISIS
A23	Assertion T82 Negated
#66	AnnotatorNotes T82	C0524376; Dependence on renal dialysis; Finding | C2945570; Encounter due to dependence on renal dialysis; Finding
T83	Observation 173 196	dependiente de diálisis
A24	Assertion T83 Negated
#67	AnnotatorNotes T83	C0524376; Dependence on renal dialysis; Finding | C2945570; Encounter due to dependence on renal dialysis; Finding
R1	Experiences Arg1:T56 Arg2:T2	
R2	Experiences Arg1:T56 Arg2:T52	
R3	Experiences Arg1:T56 Arg2:T3	
R4	Location_of Arg1:T31 Arg2:T3	
R5	Has_Duration_or_Interval Arg1:T3 Arg2:T57	
R6	Negation Arg1:T58 Arg2:T83	
R7	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T83	
R8	Experiences Arg1:T56 Arg2:T83	
R9	Experiences Arg1:T56 Arg2:T32	
R10	Experiences Arg1:T56 Arg2:T4	
R11	Negation Arg1:T59 Arg2:T80	
R12	Negation Arg1:T59 Arg2:T33	
R13	Experiences Arg1:T56 Arg2:T80	
R14	Experiences Arg1:T56 Arg2:T33	
R15	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T80	
R16	Has_Route_or_Mode Arg1:T34 Arg2:T61	
R17	Experiences Arg1:T62 Arg2:T7	
R18	Experiences Arg1:T62 Arg2:T34	
R19	Location_of Arg1:T35 Arg2:T8	
R20	Has_Duration_or_Interval Arg1:T8 Arg2:T63	
R21	Experiences Arg1:T62 Arg2:T8	
R22	Overlap Arg1:T2 Arg2:T3	
R23	Overlap Arg1:T2 Arg2:T4	
R24	Overlap Arg1:T7 Arg2:T8	
R25	Overlap Arg1:T7 Arg2:T9	
R26	Negation Arg1:T64 Arg2:T81	
R27	Negation Arg1:T64 Arg2:T36	
R28	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T81	
R29	Experiences Arg1:T62 Arg2:T81	
R30	Experiences Arg1:T62 Arg2:T36	
R31	Experiences Arg1:T62 Arg2:T9	
R32	Experiences Arg1:T62 Arg2:T82	
R33	Negation Arg1:T65 Arg2:T82	
R34	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T82	
R35	Experiences Arg1:T62 Arg2:T37	
R36	Negation Arg1:T65 Arg2:T37	
R37	Location_of Arg1:T11 Arg2:T38	
R38	Experiences Arg1:T66 Arg2:T38	
R39	Experiences Arg1:T66 Arg2:T39	
R40	Location_of Arg1:T40 Arg2:T39	
R41	Overlap Arg1:T38 Arg2:T39	
R42	Experiences Arg1:T67 Arg2:T12	
R43	Experiences Arg1:T67 Arg2:T13	
R44	Location_of Arg1:T41 Arg2:T13	
R45	Has_Duration_or_Interval Arg1:T13 Arg2:T68	
R46	Experiences Arg1:T67 Arg2:T77	
R47	Negation Arg1:T69 Arg2:T77	
R48	Negation Arg1:T69 Arg2:T42	
R49	Experiences Arg1:T67 Arg2:T42	
R50	Overlap Arg1:T12 Arg2:T14	
R51	Overlap Arg1:T12 Arg2:T13	
R52	Negation Arg1:T70 Arg2:T78	
R53	Negation Arg1:T70 Arg2:T43	
R54	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T78	
R55	Experiences Arg1:T67 Arg2:T78	
R56	Experiences Arg1:T67 Arg2:T43	
T84	Result_or_Value 900 918	≤60 ml/min/1,73 m2
R57	Has_Result_or_Value Arg1:T54 Arg2:T84	
T85	PROC 925 934	selección
#68	AnnotatorNotes T85	C0242802; Patient Selection; Research Activity
R60	Overlap Arg1:T54 Arg2:T85	
R58	Negation Arg1:T73 Arg2:T44	
R59	Overlap Arg1:T44 Arg2:T74	
T86	PROC 999 1008	selección
#69	AnnotatorNotes T86	C0242802; Patient Selection; Research Activity
R61	After Arg1:T44 Arg2:T86	
T87	PROC 1031 1040	selección
#70	AnnotatorNotes T87	C0242802; Patient Selection; Research Activity
R62	Overlap Arg1:T45 Arg2:T87	
T88	Result_or_Value 1041 1051	<10,0 g/dl
R63	Has_Result_or_Value Arg1:T45 Arg2:T88	
R64	Has_Duration_or_Interval Arg1:T17 Arg2:T76	
T89	PROC 1128 1137	selección
#71	AnnotatorNotes T89	C0242802; Patient Selection; Research Activity
R65	Before Arg1:T17 Arg2:T89	
R66	Negation Arg1:T72 Arg2:T75	
R67	Has_Quantifier_or_Qualifier Arg1:T18 Arg2:T75	
R68	Location_of Arg1:T46 Arg2:T19	
T90	PROC 1206 1215	selección
#72	AnnotatorNotes T90	C0242802; Patient Selection; Research Activity
T91	Result_or_Value 1217 1225	clase IV
R70	Has_Result_or_Value Arg1:T60 Arg2:T91	
T92	Quantifier_or_Qualifier 1194 1199	grave
#73	AnnotatorNotes T92	C1547227; Severe - Severity of Illness Code; Intellectual Product
R71	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T92	
R72	Location_of Arg1:T48 Arg2:T20	
R73	Location_of Arg1:T49 Arg2:T23	
R77	Location_of Arg1:T50 Arg2:T24	
R80	Location_of Arg1:T51 Arg2:T27	
T93	Quantifier_or_Qualifier 1379 1386	urgente
#74	AnnotatorNotes T93	C0439609; Urgent; Qualitative Concept
R81	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T93	
R82	Overlap Arg1:T28 Arg2:T79	
R83	Overlap Arg1:T27 Arg2:T79	
T94	PROC 1504 1513	selección
#75	AnnotatorNotes T94	C0242802; Patient Selection; Research Activity
R84	Before Arg1:T28 Arg2:T94	
R85	Before Arg1:T27 Arg2:T94	
R86	Causes Arg1:T25 Arg2:T29	
R87	Causes Arg1:T47 Arg2:T29	
R88	Causes Arg1:T30 Arg2:T29	
R90	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T83	
R89	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T80	
R91	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T81	
R92	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T82	
R93	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T77	
R94	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T78	
R95	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T77	
R96	Experiences Arg1:T67 Arg2:T14	
R97	Before Arg1:T85 Arg2:T44	
#76	AnnotatorNotes T39	C0748318; Progressive renal failure; Finding
#77	AnnotatorNotes T38	C4732750; Decreased hemoglobin concentration; Finding
A25	Experiencer T56 Patient
A26	Experiencer T62 Patient
A27	Experiencer T66 Patient
A28	Experiencer T67 Patient
